UTMD - Utah Medical Products Inc

https://www.utahmed.com

Strong Sell Momentum: Bearish

Recent News

Utah Medical Q1 Earnings Drop 16% on Sales Slump, Stock Up 1%

Zacks Commentary • 4 months, 1 week ago • score: 0.13

UTMD's Q1 2025 earnings fall 16% amid weak OEM sales, FX pressures and higher taxes, despite lower litigation costs and a strong cash position.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The company is headquartered in Midvale, Utah.

52W High

$67.91

52W Low

$50.98

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

0.33

Valuation

Fair

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

16.91

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

7.79

EV/Revenue (<3 favorable)

3.13

P/S (TTM) (<3 favorable)

5.23

P/B (<3 favorable)

1.73

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

7.14%

Institutions (25–75% balanced)

69.40%

Shares Outstanding

3,205,700

Float

2,763,800

Dividend Yield (2–6% sweet spot)

0.02%

Ex‑Dividend Date

2025-09-17

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

38,826,000

Gross Profit (TTM)

22,258,000

EPS (TTM)

3.75

Profit Margin (>10% good)

0.32%

Operating Margin (TTM) (higher better)

0.35%

ROE (TTM) (>15% strong)

0.10%

EPS YoY (Quarterly) (>10% good)

-0.04

Revenue YoY (Quarterly) (>8% good)

-0.04

Momentum

Bearish momentum

Value

1.5374

1.6099

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025